Celldex Therapeutics Inc (NASDAQ:CLDX)

27.80
Delayed Data
As of May 22
 +0.66 / +2.43%
Today’s Change
11.93
Today|||52-Week Range
32.82
+52.33%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 36.00, with a high estimate of 45.00 and a low estimate of 32.00. The median estimate represents a +29.50% increase from the last price of 27.80.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$479.7K
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.65%
 
 
 
 
 
 
Growthannually -6.34%
 
 
 
 
 
 

Sales

Growthquarterly -1.29%
 
 
 
 
 
 
Growthannually -38.85%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account